How a White House Autism Briefing Changed Medication Trends—and What Parents Should Know

A recent study from Brown University and Harvard Medical School highlights how quickly medical practices can shift after high-profile announcements—even without new scientific evidence. The research, published in The Lancet, found that a September 2025 White House briefing on autism led to immediate changes in how doctors prescribed two medications: acetaminophen (e.g., Tylenol) for pregnant women and leucovorin for autistic children.

What Happened—And Why It Matters

During the briefing, officials suggested a potential link between acetaminophen use during pregnancy and autism risk, while promoting leucovorin (a folate-based drug typically used for cancer or metabolic conditions) as a possible autism treatment. According to the study, emergency room acetaminophen orders for pregnant patients dropped soon after, while leucovorin prescriptions for children rose sharply—despite no new clinical trial data or updated medical guidelines at the time.

This matters to autism families because it shows how quickly both doctors and patients may change behavior based on high-profile statements, even when the science isn’t settled. As study author Dr. Michael Barnett noted, doctors may have been influenced directly or indirectly by patient requests following the briefing.

Key Takeaways for Parents

1. Ask questions about medication changes. If your child’s doctor suggests a new treatment (like leucovorin), ask about the evidence behind it and whether it’s right for your child’s specific needs.
2. Stay informed—but cautious—about breaking news. High-profile announcements can spread quickly, but they don’t always reflect the full picture. Always consult trusted medical sources or your care team.
3. Track trends in your own community. The study used data from over 1,600 hospitals, but local practices may vary. If you notice shifts in recommendations, discuss them with your provider.

Moving Forward

While research into autism treatments and risk factors is vital, this study reminds us that medical decisions should be guided by robust evidence and individualized care. If you’re considering a medication change—whether for yourself during pregnancy or for your child—take time to review the latest research and consult your healthcare team.

Learn more: Read the full study via Brown University’s report (March 5, 2026).